company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21331000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,499000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,21830000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,263000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,28000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,28000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,,totalassets,Total Assets,=,debit,usd,22121000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,289000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2915000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3204000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3229000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,151596000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-151776000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,19072000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,18892000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,18892000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,18892000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,,2011-06-30,2011-08-08 16:37:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,22121000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21019000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,301000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,21320000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,346000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,,totalassets,Total Assets,=,debit,usd,21796000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,433000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2107000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2540000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,64000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,64000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2604000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,175170000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-155978000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,19192000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,19192000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,19192000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,,2011-09-30,2011-11-07 16:34:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,21796000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13444000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,306000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,13750000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1114000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,,totalassets,Total Assets,=,debit,usd,14994000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,890000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2328000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,143000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3361000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3361000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,176793000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-165160000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,11633000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,11633000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11633000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,,2012-03-31,2012-05-10 13:57:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,14994000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12442000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,557000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,12999000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1102000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,,totalassets,Total Assets,=,debit,usd,14231000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,605000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2272000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,239000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3116000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3116000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,180844000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-169729000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,11115000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,11115000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11115000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,,2012-06-30,2012-08-09 13:14:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,14231000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60048000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,355000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,60403000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1228000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,,totalassets,Total Assets,=,debit,usd,61761000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1758000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2121000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,365000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4244000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4244000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,233367000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-175850000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,57517000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,57517000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,57517000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,,2012-09-30,2012-11-05 15:30:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,61761000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,45722000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,427000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,46149000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2700000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,,totalassets,Total Assets,=,debit,usd,48979000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3825000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3149000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,622000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7596000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7596000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,237923000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-196540000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,41383000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,41383000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,41383000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,,2013-03-31,2013-05-10 14:34:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,48979000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34849000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,360000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,35209000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2733000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,148000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,148000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,,totalassets,Total Assets,=,debit,usd,38090000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5350000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3488000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,754000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9592000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9592000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,240452000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-211954000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,28498000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,28498000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,28498000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,,2013-06-30,2013-08-08 06:08:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,38090000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22597000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,763000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,23360000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2857000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,153000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,153000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,,totalassets,Total Assets,=,debit,usd,26370000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2250000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2360000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,888000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5498000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5498000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,245699000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-224827000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,20872000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,20872000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,20872000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,,2013-09-30,2013-11-12 08:46:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,26370000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,57475000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2262000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,59737000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2926000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,,totalassets,Total Assets,=,debit,usd,62793000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3603000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2617000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1164000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7384000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7384000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,311817000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-256408000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,55409000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,55409000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,55409000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,,2014-03-31,2014-05-12 16:43:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,62793000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55556000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,945000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,56501000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2996000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,,totalassets,Total Assets,=,debit,usd,59627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2383000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5838000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1656000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1749000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11626000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11626000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,383808000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-335807000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,48001000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,48001000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,48001000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,,2015-03-31,2015-05-08 15:23:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,59627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,171526000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1895000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,173421000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2905000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,,totalassets,Total Assets,=,debit,usd,176456000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2987000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9416000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2284000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1903000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16590000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16590000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,518780000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-358914000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,159866000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,159866000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,159866000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,,2015-06-30,2015-08-07 14:51:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,176456000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,152989000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2006000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,154995000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2982000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,174000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,174000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,,totalassets,Total Assets,=,debit,usd,158151000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2735000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8265000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3389000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2061000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16450000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16450000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,523287000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-381586000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,141701000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,141701000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,141701000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,,2015-09-30,2015-11-06 15:20:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,158151000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,68016000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,32391000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2744000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5050000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,108201000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3645000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,,totalassets,Total Assets,=,debit,usd,111846000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6861000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6952000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2969000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2388000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19170000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19170000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,538948000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-446273000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,92676000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,92676000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,92676000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,,2016-03-31,2016-05-05 16:20:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,111846000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61943000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12700000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3312000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3175000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,81130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4471000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,,totalassets,Total Assets,=,debit,usd,85731000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8661000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11997000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4674000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2558000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27890000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,27890000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,547341000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-489499000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,57841000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,57841000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,57841000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,,2016-06-30,2016-08-08 16:49:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85731000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,45640000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,43279000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1983000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3072000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,93974000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4702000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,,totalassets,Total Assets,=,debit,usd,98806000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6090000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13463000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8641000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2732000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30926000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,50000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,50000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,80926000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,555905000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-538008000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-17000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,17880000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,17880000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,17880000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,,2016-09-30,2016-11-08 16:31:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,98806000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,83513000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,81703000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10327000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4641000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3431000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,183615000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5680000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,263000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,263000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,,totalassets,Total Assets,=,debit,usd,189558000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4477000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18468000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5235000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6122000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3096000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,37398000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,50000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,50000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,87398000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,738490000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-636300000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-30000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,102160000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,102160000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,102160000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,,2017-03-31,2017-05-10 08:16:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,189558000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,30277000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,78986000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,18616000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4801000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3673000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,136353000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5754000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,263000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,263000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,,totalassets,Total Assets,=,debit,usd,142370000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6315000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,26649000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4788000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7258000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3285000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,48295000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,73295000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,748180000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-679099000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,69075000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,69075000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,69075000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,,2017-06-30,2017-08-09 16:35:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,142370000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65524000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,8492000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,28851000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5169000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4554000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,112590000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5343000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,263000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,263000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,,totalassets,Total Assets,=,debit,usd,118196000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5337000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,30915000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5560000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7850000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3481000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53143000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,78143000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,761018000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-720965000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,40053000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,40053000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,40053000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,,2017-09-30,2017-11-06 08:46:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,118196000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46575000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,67363000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,37713000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,19418000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5494000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,176563000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6504000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,316000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,316000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,,totalassets,Total Assets,=,debit,usd,183383000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11458000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,45577000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5248000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3894000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,91177000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,91177000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,926395000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-834147000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-42000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,92206000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,92206000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,92206000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,,2018-03-31,2018-05-10 08:55:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,183383000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,258934000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,164030000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,45886000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,27197000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6577000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,502624000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7505000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,427000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,427000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,,totalassets,Total Assets,=,debit,usd,510556000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4979000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,37688000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6886000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4112000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,78665000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,78665000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1304732000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-872816000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-25000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,431891000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,431891000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,431891000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,,2018-06-30,2018-08-08 08:47:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,510556000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53934000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,310866000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,53633000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,31412000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10217000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,460062000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,10581000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,253000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,253000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,,totalassets,Total Assets,=,debit,usd,470896000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9644000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,41649000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8457000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4338000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,64088000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,64088000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1318012000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-911162000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-42000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,406808000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,406808000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,406808000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,,2018-09-30,2018-11-07 16:19:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,470896000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23461000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,265777000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,74007000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,31421000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,11539000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,406205000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16267000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13322000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13322000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,,totalassets,Total Assets,=,debit,usd,435794000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10811000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,67953000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6640000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6853000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,92257000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11723000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11723000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,103980000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1355511000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1023733000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,36000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,331814000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,331814000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,331814000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,,2019-03-31,2019-05-09 08:40:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,435794000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53038000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,223000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,66821000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,29270000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8739000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,380835000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17910000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12921000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12921000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,,totalassets,Total Assets,=,debit,usd,411666000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7997000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,71274000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8982000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6803000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,95056000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11251000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11251000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,106307000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1379166000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1073955000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,148000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,305359000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,305359000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,305359000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,,2019-06-30,2019-08-05 08:46:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,411666000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60108000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,196170000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,66955000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,24172000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,16742000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,364147000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16315000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,,totalassets,Total Assets,=,debit,usd,392962000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,77901000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,10134000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7075000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,96737000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10783000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10783000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,107520000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1392889000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1107550000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,103000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,285442000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,285442000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,285442000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,,2019-09-30,2019-11-12 08:46:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,392962000.0
